207 related articles for article (PubMed ID: 34966465)
1. Identification of the 7-lncRNA Signature as a Prognostic Biomarker for Acute Myeloid Leukemia.
Liu CY; Guo HH; Li HX; Liang Y; Tang C; Chen NN
Dis Markers; 2021; 2021():8223216. PubMed ID: 34966465
[TBL] [Abstract][Full Text] [Related]
2. Identification of seven novel ferroptosis-related long non-coding RNA signatures as a diagnostic biomarker for acute myeloid leukemia.
Zheng Z; Wu W; Lin Z; Liu S; Chen Q; Jiang X; Xue Y; Lin D
BMC Med Genomics; 2021 Sep; 14(1):236. PubMed ID: 34579730
[TBL] [Abstract][Full Text] [Related]
3. Identification of circRNA-lncRNA-miRNA-mRNA Competitive Endogenous RNA Network as Novel Prognostic Markers for Acute Myeloid Leukemia.
Cheng Y; Su Y; Wang S; Liu Y; Jin L; Wan Q; Liu Y; Li C; Sang X; Yang L; Liu C; Wang Z
Genes (Basel); 2020 Jul; 11(8):. PubMed ID: 32751923
[TBL] [Abstract][Full Text] [Related]
4. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a 4 lncRNAs-based prognostic risk scoring system in adults with acute myeloid leukemia.
Zeng H; Wu H; Yan M; Tang L; Guo X; Zhao X
Leuk Res; 2020 Jan; 88():106261. PubMed ID: 31739140
[TBL] [Abstract][Full Text] [Related]
6. Immune-relatedlncRNAs can predict the prognosis of acute myeloid leukemia.
Li R; Wu S; Wu X; Zhao P; Li J; Xue K; Li J
Cancer Med; 2022 Feb; 11(3):888-899. PubMed ID: 34904791
[TBL] [Abstract][Full Text] [Related]
7. Cuproptosis-related lncRNA signature for prognostic prediction in patients with acute myeloid leukemia.
Zhu Y; He J; Li Z; Yang W
BMC Bioinformatics; 2023 Feb; 24(1):37. PubMed ID: 36737692
[TBL] [Abstract][Full Text] [Related]
8. A three‑lncRNA signature for prognosis prediction of acute myeloid leukemia in patients.
Wang F; Tian X; Zhou J; Wang G; Yu W; Li Z; Fan Z; Zhang W; Liang A
Mol Med Rep; 2018 Aug; 18(2):1473-1484. PubMed ID: 29901168
[TBL] [Abstract][Full Text] [Related]
9. The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature.
Díaz-Beyá M; Brunet S; Nomdedéu J; Pratcorona M; Cordeiro A; Gallardo D; Escoda L; Tormo M; Heras I; Ribera JM; Duarte R; de Llano MP; Bargay J; Sampol A; Nomdedeu M; Risueño RM; Hoyos M; Sierra J; Monzo M; Navarro A; Esteve J;
Oncotarget; 2015 Oct; 6(31):31613-27. PubMed ID: 26436590
[TBL] [Abstract][Full Text] [Related]
10. Establishment of tumor protein p53 mutation-based prognostic signatures for acute myeloid leukemia.
Xie J; Chen K; Han H; Dong Q; Wang W
Curr Res Transl Med; 2022 Sep; 70(4):103347. PubMed ID: 35483237
[TBL] [Abstract][Full Text] [Related]
11. A 10-Long Non-Coding RNA-Based Expression Signature as a Potential Biomarker for Prognosis of Acute Myeloid Leukemia.
Tang P; Xie M; Wei Y; Xie X; Chen D; Jiang Z
Med Sci Monit; 2019 Jul; 25():4999-5004. PubMed ID: 31278736
[TBL] [Abstract][Full Text] [Related]
12. The prognostic impact of abnormally expressed, long noncoding RNAs in acute myeloid leukemia: a meta-analysis.
Shi J; Shi X; Dai RQ
Hematology; 2020 Dec; 25(1):219-228. PubMed ID: 33346694
[No Abstract] [Full Text] [Related]
13. A novel seven-lncRNA signature for prognosis prediction in hepatocellular carcinoma.
Yan J; Zhou C; Guo K; Li Q; Wang Z
J Cell Biochem; 2019 Jan; 120(1):213-223. PubMed ID: 30206981
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive long non-coding RNA expression profiling by RNA sequencing reveals potential biomarkers for acute myeloid leukemia risk.
Wang Y
Cancer Biomark; 2019; 26(1):93-108. PubMed ID: 31356197
[TBL] [Abstract][Full Text] [Related]
15. Identification of the Integrated Prognostic Signature Associated with Immuno-relevant Genes and Long Non-coding RNAs in Acute Myeloid Leukemia.
Zhao C; Wang Y; Sharma A; Wang Z; Zheng C; Wei Y; Wu Y; Liu P; Liu J; Zhan X; Schmidt-Wolf I; Tu F
Cancer Invest; 2022 Sep; 40(8):663-674. PubMed ID: 35770858
[TBL] [Abstract][Full Text] [Related]
16. Five cuprotosis-related lncRNA signatures for prognosis prediction in acute myeloid leukaemia.
Wang Q
Hematology; 2023 Dec; 28(1):2231737. PubMed ID: 37417765
[TBL] [Abstract][Full Text] [Related]
17. lncRNA co-expression network model for the prognostic analysis of acute myeloid leukemia.
Pan JQ; Zhang YQ; Wang JH; Xu P; Wang W
Int J Mol Med; 2017 Mar; 39(3):663-671. PubMed ID: 28204819
[TBL] [Abstract][Full Text] [Related]
18. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
19. The implication of lncRNA expression pattern and potential function of lncRNA RP4-576H24.2 in acute myeloid leukemia.
Zheng J; Song Y; Li Z; Tang A; Fei Y; He W
Cancer Med; 2019 Dec; 8(17):7143-7160. PubMed ID: 31568697
[TBL] [Abstract][Full Text] [Related]
20. Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid Leukemia.
Papaioannou D; Nicolet D; Ozer HG; Mrózek K; Volinia S; Fadda P; Carroll AJ; Kohlschmidt J; Kolitz JE; Wang ES; Stone RM; Byrd JC; Garzon R; Bloomfield CD
Mol Cancer Ther; 2019 Aug; 18(8):1451-1459. PubMed ID: 31164409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
